Avalyn Pharma Inc.
AVLNNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $812.13M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $22.24$40.17
- Volume (live)
- -
- Avg. volume (3M)
- 310.63K
Avalyn Pharma (AVLN) Stock Price & Financial Analysis
Avalyn Pharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $25.10 - $27.57 |
|---|---|
| 52-Week High | $40.17 |
| 52-Week Low | $22.24 |
| Open | $25.12 |
| Volume (last close) | 286.74K |
| Average Volume (3M) | 310.63K |
| 50-Day MA | $32.03 |
|---|
| Market Cap | 812.13M |
|---|---|
| Shares Outstanding | 29.65M |
| Price to Book (P/B) | 2.04 |
| EV/EBITDA | -5.66 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Avalyn Pharma at a Glance
As of the Oct 22, 2026 close, Avalyn Pharma (AVLN) has a market capitalization of $812.13M.
As of its latest reported balance sheet, it holds $264.20M in cash and securities against $15.62M of debt, a net cash position of $248.58M.
Avalyn Pharma does not currently pay a dividend.
At $27.39 (the Oct 22, 2026 close) it sits within its 52-week range of $22.24 to $40.17.
Frequently Asked Questions About Avalyn Pharma
What is the current stock price for AVLN?
As of the Oct 22, 2026 close, AVLN stock trades at $27.39. The 52-week range is $22.24–$40.17, with a day range of $25.10–$27.57.
What is the P/E ratio for AVLN?
The P/E ratio (Price-to-Earnings) for AVLN is shown in the Key Statistics section. This valuation metric helps compare Avalyn Pharma Inc. to industry peers.
Does AVLN pay dividends?
Avalyn Pharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for AVLN?
Analyst ratings and recommendations for AVLN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of AVLN?
As of the Oct 22, 2026 close, Avalyn Pharma's market capitalization is $812.1M, classifying it as a small-cap company. Avalyn Pharma operates in the Healthcare sector within the Biotechnology industry.